-

Shareholder Alert: Robbins LLP Reminds Investors that Loop Industries, Inc. (LOOP) is Being Sued for Misleading Shareholders

SAN DIEGO & TERREBONNE, Quebec--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds purchasers of the class action filed against Loop Industries, Inc. (NASDAQ: LOOP) for alleged violations of the Securities Exchange Act of 1934 between September 24, 2018 and October 12, 2020. Loop Industries, Inc. claims to own proprietary technology that depolymerizes waste polyethylene terephthalate (PET) plastics and polyester fibers into PET resin for food-grade packaging.

If you suffered a loss due to Loop Industries, Inc.'s misconduct, click here.

Loop Industries, Inc. (LOOP) Accused of Deceiving Consumers and Investors

According to the complaint, during the class period, the company falsely touted the strength of Loop's technological and operational profile. On October 13, 2020, Hidenburg Research published a report titled “Loop Industries: Former Employees and Plastics Experts Blow The Whistle On This ‘Recycled’ Smoke And Mirrors Show.” According to the report, Loop Industries' scientists were under pressure from CEO Daniel Solomita to lie about the results of the company's process. Hidenburg also alleged that the Company did not have the proprietary process or technology to break PET down to its base chemicals at a recovery rate of 100% and that it would have been 'technically and industrially impossible' to do so. The report purported that a key partner Tysenkrupp put an indefinite hold on their global alliance agreement as Loop 'underestimated' both costs and complexities of its process. On this news, Loop's stock dropped 32% to close at $7.83, and continues to decline.

If you purchased Loop Industries, Inc. (LOOP) securities between September 24, 2018 and October 12, 2020, you have until December 14, 2020, to ask the court to appoint you lead plaintiff for the class.

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Loop Industries, Inc. settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the uniQure N.V. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired uniQure N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025. uniQure is a biotechnology company developing gene therapies for rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that un...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025. POMDoctor claims to be "a leading online medical services platform for chronic diseases in China." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Alleg...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Inovio Pharmaceuticals, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all persons that purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025. Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papillomavirus (“HPV”). For more information, submit a...
Back to Newsroom